{"id":59322,"date":"2024-02-28T05:52:41","date_gmt":"2024-02-28T05:52:41","guid":{"rendered":"https:\/\/medsname.com\/simvotin\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"simvotin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/simvotin\/","title":{"rendered":"Simvotin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Simvotin?<\/h3>\n<p style=\"margin:0;\"><strong>Simvotin<\/strong> egy m\u00e1rka <strong>simvastatin<\/strong> (10 mg or 20 mg), a <strong>sztatin (HMG-CoA-redukt\u00e1z g\u00e1tl\u00f3)<\/strong> alkalmaz\u00e1sa <strong>az LDL (\u201crossz\u201d) koleszterin cs\u00f6kkent\u00e9s\u00e9re \u00e9s sz\u00edv- \u00e9s \u00e9rrendszeri esem\u00e9nyek (pl. sz\u00edvroham, agyi \u00e9rkatasztr\u00f3fa, sz\u00edv- \u00e9s \u00e9rrendszeri hal\u00e1l) kock\u00e1zat\u00e1nak cs\u00f6kkent\u00e9s\u00e9re emelkedett koleszterinszint\u0171 vagy m\u00e1r megl\u00e9v\u0151 sz\u00edv- \u00e9s \u00e9rrendszeri betegs\u00e9gben szenved\u0151 betegekn\u00e9l. A sztatinok<\/strong> legszil\u00e1rdabb eredm\u00e9nybizony\u00edt\u00e9kkal rendelkeznek <strong>minden m\u00e1s lipidcs\u00f6kkent\u0151 gy\u00f3gyszeroszt\u00e1lyhoz k\u00e9pest: kb. 22%-os cs\u00f6kken\u00e9st mutatnak a s\u00falyos vascularis esem\u00e9nyekben 1 mmol\/L LDL-C cs\u00f6kken\u00e9s eset\u00e9n (CTT meta-anal\u00edzis, &gt;170 000 beteg).<\/strong> Magas intenzit\u00e1s\u00fa. <strong>Moderate-intensity<\/strong> at 20&ndash;40&nbsp;mg\/day (lowers LDL-C by ~30&ndash;40%). The classic moderate-intensity statin. Has among the largest outcome-trial datasets (4S, HPS, A to Z, SEARCH) for cardiovascular event reduction. The catch is extensive CYP3A4 metabolism \u2014 more drug interactions than rosuvastatin or pitavastatin. Main side effects: muscle aches (5&ndash;10%, usually mild), mild transaminase elevation, small new-onset diabetes signal in at-risk patients. Rare but serious: rhabdomyolysis, immune-mediated necrotising myopathy. <strong>Ker\u00fclend\u0151 terhess\u00e9g alatt<\/strong> (category X). <strong>Evening or bedtime dosing matters<\/strong> \u2014 HMG-CoA reductase activity peaks overnight, so evening-dosed simvastatin gives about 10% greater LDL reduction than morning dosing.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<h2 class=\"wp-block-heading\">What Is Simvotin?<\/h2>\n<p>Simvotin is an oral lipid-lowering medicine containing <strong>simvastatin<\/strong> (10 mg or 20 mg), manufactured by WHO-GMP certified manufacturer. Supplied in packs of 30, 60, 90 or 180 tablets. Originator brand: Zocor (Merck, 1988).<\/p>\n<p>simvastatin belongs to the <strong>sztatinok oszt\u00e1ly\u00e1ba<\/strong> (HMG-CoA redukt\u00e1z g\u00e1tl\u00f3k) tartozik, amelyek a vil\u00e1g legsz\u00e9lesebb k\u00f6rben fel\u00edrt \u00e9s legjobban bizony\u00edtott koleszterincs\u00f6kkent\u0151 gy\u00f3gyszerei. A sztatinok szerepelnek a WHO alapvet\u0151 gy\u00f3gyszereinek list\u00e1j\u00e1n, \u00e9s els\u0151vonalbeli ter\u00e1pi\u00e1t k\u00e9pviselnek szinte minden modern kardiovaszkul\u00e1ris megel\u0151z\u0151 ir\u00e1nyelvben (ACC\/AHA, ESC\/EAS, NICE, CCS). <strong>Moderate-intensity<\/strong> at 20&ndash;40&nbsp;mg\/day (lowers LDL-C by ~30&ndash;40%).<\/p>\n<h2 class=\"wp-block-heading\">What Is Simvotin Used For?<\/h2>\n<ul>\n<li><strong>Els\u0151dleges megel\u0151z\u00e9s<\/strong> az ateroszklerotikus kardiovaszkul\u00e1ris betegs\u00e9g (ASCVD) eset\u00e9n emelkedett 10 \u00e9ves kock\u00e1zattal rendelkez\u0151 egy\u00e9nekn\u00e9l (\u00e1ltal\u00e1ban \u2265 7,5\u201310% vagy t\u00f6bb kock\u00e1zati t\u00e9nyez\u0151 eset\u00e9n)<\/li>\n<li><strong>M\u00e1sodlagos megel\u0151z\u00e9s<\/strong> sz\u00edvinfarktus, stroke\/TIA, t\u00fcneti perif\u00e9ri\u00e1s \u00e9rbetegs\u00e9g vagy revascularisatio ut\u00e1n \u2014 ezeknek a betegeknek magas intenzit\u00e1s\u00fa sztatinter\u00e1pia sz\u00fcks\u00e9ges, f\u00fcggetlen\u00fcl az alap LDL-szintt\u0151l<\/li>\n<li><strong>Familialis hypercholesterinaemia<\/strong> (heterozig\u00f3ta \u00e9s, kieg\u00e9sz\u00edt\u0151kkel, homozig\u00f3ta)<\/li>\n<li><strong>2-es t\u00edpus\u00fa diabetes tov\u00e1bbi kock\u00e1zati t\u00e9nyez\u0151kkel<\/strong> \u2014 a sztatint \u00e1ltal\u00e1ban a diagn\u00f3zis fel\u00e1ll\u00edt\u00e1s\u00e1t\u00f3l kezdve adj\u00e1k<\/li>\n<li><strong>Kr\u00f3nikus veseel\u00e9gtelens\u00e9g<\/strong> (CKD) \u2014 a legt\u00f6bb ir\u00e1nyelv sztatin \u00b1 ezetimibe alkalmaz\u00e1s\u00e1t javasolja CKD 3\u20135. st\u00e1diumban, dial\u00edzisre nem ker\u00fcl\u0151 betegekn\u00e9l<\/li>\n<li>N\u00e9h\u00e1ny forma <strong>vegyes diszlipid\u00e9mia<\/strong> (emelkedett LDL \u00e9s triglicerid szint mellett)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">How Does Simvotin Work?<\/h2>\n<p>simvastatin is a competitive inhibitor of <strong>HMG-CoA redukt\u00e1znak<\/strong>, amely a m\u00e1jban a koleszterin bioszint\u00e9zis sebess\u00e9g\u00e9t meghat\u00e1roz\u00f3 enzim. Ennek az enzimnek a g\u00e1tl\u00e1sa sz\u00e1mos hat\u00e1ssal j\u00e1r:<\/p>\n<ul>\n<li><strong>Cs\u00f6kkenti a sejten bel\u00fcli koleszterint<\/strong> a hepatocyt\u00e1kban<\/li>\n<li><strong>Fokozza az LDL-receptorok kifejez\u0151d\u00e9s\u00e9t<\/strong> a hepatocita felsz\u00edn\u00e9n \u2014 a m\u00e1j t\u00f6bb LDL-t von ki a v\u00e9rb\u0151l<\/li>\n<li><strong>Cs\u00f6kkenti a plazma LDL-C szintj\u00e9t<\/strong> 25\u201360%-kal, a sztatin t\u00edpus\u00e1t\u00f3l \u00e9s adagj\u00e1t\u00f3l f\u00fcgg\u0151en<\/li>\n<li><strong>Enyh\u00e9n cs\u00f6kkenti a triglicerid szintet<\/strong> (10\u201330%) \u00e9s n\u00f6veli a HDL-C szintet (5\u201310%)<\/li>\n<li><strong>Stabiliz\u00e1lja az atheroscleroticus plakkokat<\/strong> \u2014 pleiotrop hat\u00e1sok a gyullad\u00e1sra, az endot\u00e9lfunkci\u00f3ra \u00e9s a thrombocyta-reaktivit\u00e1sra (r\u00e9szben LDL-f\u00fcggetlen)<\/li>\n<\/ul>\n<p><strong>Farmakokinetika:<\/strong> Extensively metabolised by <strong>CYP3A4<\/strong> \u2014 this drives most of its drug interactions. Half-life: 1.9 hours (simvastatin) \/ 4&ndash;7 hours (active acid metabolite). <strong>Evening or bedtime dosing matters<\/strong> \u2014 HMG-CoA reductase activity peaks overnight, so evening-dosed simvastatin gives about 10% greater LDL reduction than morning dosing.<\/p>\n<p>Klinikai hat\u00e1s: LDL-C 2 h\u00e9ten bel\u00fcl cs\u00f6kken, k\u00f6zel maxim\u00e1lis \u00e9rt\u00e9ket 4\u20136 h\u00e9t alatt \u00e9r el. Lipidszint \u00e9s ALT ellen\u0151rz\u00e9se 6\u201312 h\u00e9ttel a kezel\u00e9s megkezd\u00e9se vagy d\u00f3zism\u00f3dos\u00edt\u00e1s ut\u00e1n.<\/p>\n<h2 class=\"wp-block-heading\">Adagol\u00e1s \u00e9s alkalmaz\u00e1s<\/h2>\n<p>Start 10&ndash;20&nbsp;mg once daily in the evening (bedtime). Typical maintenance: 20&ndash;40&nbsp;mg\/day. <strong>Do not exceed 40&nbsp;mg\/day<\/strong> in most patients \u2014 the 80&nbsp;mg dose was restricted by the FDA in 2011 due to disproportionate myopathy and rhabdomyolysis risk.<\/p>\n<ul>\n<li>Bevehet\u0151 \u00e9tkez\u00e9ssel vagy an\u00e9lk\u00fcl.<\/li>\n<li>Ha kihagy egy adagot \u2014 vegye be, amint esz\u00e9be jut. Hagyja ki, ha k\u00f6zel van a k\u00f6vetkez\u0151 adaghoz; ne dupl\u00e1zza meg az adagot.<\/li>\n<li><strong>Etnikai megfontol\u00e1sok:<\/strong> No specific ethnic adjustment.<\/li>\n<li><strong>Az \u00e9letm\u00f3d kieg\u00e9sz\u00edt\u0151 hat\u00e1s\u00fa.<\/strong> M\u00e9g a maxim\u00e1lis sztatind\u00f3zis mellett is a t\u00e1pl\u00e1lkoz\u00e1s jav\u00edt\u00e1sa (mediterr\u00e1n vagy DASH-minta), fogy\u00e1s \u00e9s rendszeres testmozg\u00e1s tov\u00e1bbi 5\u201315%-os LDL-cs\u00f6kken\u00e9st eredm\u00e9nyezhet a gy\u00f3gyszer hat\u00e1s\u00e1ra.<\/li>\n<li><strong>A betart\u00e1s mindent meghat\u00e1roz.<\/strong> A sztatinok csak akkor hatnak, ha szedi \u0151ket; a \u201cnorm\u00e1lis\u201d koleszterinszint el\u00e9r\u00e9se ut\u00e1n val\u00f3 abbahagy\u00e1s eset\u00e9n az LDL-szint heteken bel\u00fcl visszaemelkedik a kezel\u00e9s el\u0151tti szintre, \u00e9s a kardiovaszkul\u00e1ris esem\u00e9nyek kock\u00e1zata is k\u00f6veti.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Mell\u00e9khat\u00e1sok<\/h2>\n<p>A sztatinok \u00e1ltal\u00e1ban j\u00f3l toler\u00e1lhat\u00f3k. Nagy randomiz\u00e1lt vizsg\u00e1latokban a placebohoz k\u00e9pest csak kis m\u00e9rt\u00e9k\u0171 mell\u00e9khat\u00e1s-ar\u00e1nyt mutatnak.<\/p>\n<p><strong>Gyakori:<\/strong><\/p>\n<ul>\n<li><strong>Izomt\u00fcnetek (SAMS \u2014 sztatinhoz t\u00e1rs\u00edtott izomt\u00fcnetek)<\/strong> \u2014 f\u00e1jdalom, merevs\u00e9g, enyhe gyenges\u00e9g. Ny\u00edlt megfigyel\u00e9ses adatok szerint a felhaszn\u00e1l\u00f3k 5\u201310%-a jelzi; a randomiz\u00e1lt vizsg\u00e1latok (SAMSON, StatinWISE) azt mutatj\u00e1k, hogy az izomt\u00fcnetek t\u00f6bbs\u00e9ge, amelyet a sztatinoknak tulajdon\u00edtanak, val\u00f3j\u00e1ban nem ezek okozz\u00e1k (nocebo-hat\u00e1s). Val\u00f3di sztatinhoz kapcsol\u00f3d\u00f3 myalgia el\u0151fordulhat, \u00e9s \u00e1ltal\u00e1ban a szed\u00e9s abbahagy\u00e1s\u00e1val megsz\u0171nik; pr\u00f3b\u00e1ljon ki m\u00e1sik sztatint vagy alacsonyabb d\u00f3zist.<\/li>\n<li><strong>Enyhe transzamin\u00e1z-emelked\u00e9s<\/strong> (ALT\/AST legfeljebb 3\u00d7 ULN) \u2014 \u00e1ltal\u00e1ban t\u00fcnetmentes, gyakran a szed\u00e9s abbahagy\u00e1sa n\u00e9lk\u00fcl is megsz\u0171nik.<\/li>\n<li>Gyomor-b\u00e9lrendszeri panaszok, fejf\u00e1j\u00e1s, sz\u00e9d\u00fcl\u00e9s<\/li>\n<li>Alv\u00e1szavar (ink\u00e1bb a lipofil sztatinokn\u00e1l, mint p\u00e9ld\u00e1ul a szimvasztatinn\u00e1l)<\/li>\n<\/ul>\n<p><strong>Nem gyakori, de fontos:<\/strong><\/p>\n<ul>\n<li><strong>\u00dajonnan kialakul\u00f3 2-es t\u00edpus\u00fa diabetes<\/strong> \u2014 kis abszol\u00fat n\u00f6veked\u00e9s (~1 extra eset 200 bet\u00e9g\u00e9v alatt) a m\u00e1r megl\u00e9v\u0151 diabetes kock\u00e1zati t\u00e9nyez\u0151kkel rendelkez\u0151kn\u00e9l. A sz\u00edv- \u00e9s \u00e9rrendszeri el\u0151ny\u00f6k t\u00fals\u00falyban vannak a diabetes kock\u00e1zat\u00e1val szemben minden olyan kock\u00e1zati csoportban, ahol sztatin indokolt.<\/li>\n<li><strong>Rabdomiol\u00edzis<\/strong> \u2014 nagyon ritka (&lt; 0,1%). S\u00falyos izomf\u00e1jdalom + s\u00f6t\u00e9t vizelet + jelent\u0151sen emelkedett CK. Szak\u00edtsa meg a gy\u00f3gyszer szed\u00e9s\u00e9t \u00e9s keressen orvosi seg\u00edts\u00e9get.<\/li>\n<li><strong>Immunmedi\u00e1lt necrotiz\u00e1l\u00f3 miop\u00e1tia<\/strong> \u2014 ritka autoimmun izombetegs\u00e9g, amely sztatin expoz\u00edci\u00f3t k\u00f6vet\u0151en jelentkezik; a gy\u00f3gyszer abbahagy\u00e1sa ut\u00e1n is fennmarad \u00e9s immunszuppresszi\u00f3ra van sz\u00fcks\u00e9g. Anti-HMGCR antitestek pozit\u00edvak.<\/li>\n<li><strong>S\u00falyos m\u00e1jk\u00e1rosod\u00e1s<\/strong> \u2014 nagyon ritka.<\/li>\n<li>Perif\u00e9ri\u00e1s neurop\u00e1tia \u2014 ritka<\/li>\n<li>Kognit\u00edv panaszok (eml\u00e9kezetk\u00f6d) \u2014 jelentve, de nagyobb vizsg\u00e1latokban nem er\u0151s\u00edtett\u00e9k meg az ok-okozati \u00f6sszef\u00fcgg\u00e9st<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<p><strong>Avoid or dose-limit<\/strong> with: strong CYP3A4 inhibitors (itraconazole, ketoconazole, clarithromycin, erythromycin, HIV protease inhibitors, cobicistat) \u2014 contraindicated combinations. <strong>Grapefruitl\u00e9<\/strong> \u2014 avoid, raises simvastatin levels several-fold. <strong>Amlodipine, amiodarone, diltiazem, verapamil, dronedarone, ranolazine<\/strong> \u2014 limit simvastatin to 20&nbsp;mg\/day. <strong>Gemfibrozil<\/strong> \u2014 contraindicated; severe myopathy risk. <strong>Fenofibrate, niacin &ge; 1&nbsp;g\/day<\/strong> \u2014 use cautiously.<\/p>\n<h2 class=\"wp-block-heading\">Who Should Not Take Simvotin?<\/h2>\n<ul>\n<li><strong>Terhess\u00e9g<\/strong> (X kateg\u00f3ria) \u2013 sz\u00fcneteltetni kell a fogantat\u00e1s el\u0151tt; a sztatinok nem terhess\u00e9gi koleszterin-szerek<\/li>\n<li><strong>Szoptat\u00e1s<\/strong> \u2013 ker\u00fclend\u0151<\/li>\n<li>Akt\u00edv m\u00e1jbetegs\u00e9g vagy tart\u00f3s, magyar\u00e1zatlan transzamin\u00e1z-emelked\u00e9s &gt; 3\u00d7 ULN<\/li>\n<li>Ismert sztatin-allergia<\/li>\n<li>Sztatin-induk\u00e1lt miop\u00e1tia vagy rabdomiol\u00edzis a k\u00f3rel\u0151zm\u00e9nyben<\/li>\n<li>S\u00falyos veseel\u00e9gtelens\u00e9g \u2013 d\u00f3zism\u00f3dos\u00edt\u00e1s sz\u00fcks\u00e9ges (k\u00fcl\u00f6n\u00f6sen rosuvasztatin eset\u00e9n)<\/li>\n<li>Egyes alkoholhoz k\u00f6thet\u0151 m\u00e1jbetegs\u00e9gek<\/li>\n<li>Egyidej\u0171leg szedett szigor\u00faan ellenjavallt gy\u00f3gyszerek (statinonk\u00e9nt v\u00e1ltozik \u2013 l\u00e1sd a Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sokat)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1s<\/h2>\n<p>Store Simvotin below 25&deg;C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Is Simvotin the same as simvastatin?<\/h3>\n<p>Yes &mdash; Simvotin contains the active ingredient simvastatin. Bioequivalence to the originator brand (Zocor (Merck, 1988)) is required by regulatory authorities, so clinical effect is the same at the same dose.<\/p>\n<h3 class=\"wp-block-heading\">Is simvastatin as good as atorvastatin or rosuvastatin?<\/h3>\n<p>For LDL-lowering potency: <strong>rosuvastatin &gt; atorvastatin &gt; simvastatin &gt; pravastatin<\/strong>. Simvastatin 40&nbsp;mg is roughly equivalent to atorvastatin 10&nbsp;mg or rosuvastatin 5&nbsp;mg. For patients needing &gt; 40% LDL reduction (high-risk primary prevention or secondary prevention), atorvastatin 20&ndash;80&nbsp;mg or rosuvastatin 10&ndash;40&nbsp;mg is usually preferred over simvastatin. Simvastatin remains a reasonable low-cost choice in low-to-moderate risk patients without the interaction problems (not on CYP3A4 inhibitors, not on amlodipine\/amiodarone combinations).<\/p>\n<h3 class=\"wp-block-heading\">When should I take Simvotin &mdash; morning or evening?<\/h3>\n<p><strong>Evening or bedtime dosing matters<\/strong> \u2014 HMG-CoA reductase activity peaks overnight, so evening-dosed simvastatin gives about 10% greater LDL reduction than morning dosing.<\/p>\n<h3 class=\"wp-block-heading\">Do I need to take Simvotin for life?<\/h3>\n<p>A legt\u00f6bb esetben igen. A sztatinok csak akkor hatnak, am\u00edg szedj\u00fck \u0151ket. M\u00e1sodlagos megel\u0151z\u00e9s eset\u00e9n (sz\u00edvroham, stroke, stentel\u00e9s ut\u00e1n) l\u00e9nyeg\u00e9ben \u00e9lethossziglan sz\u00fcks\u00e9gesek. Els\u0151dleges megel\u0151z\u00e9s eset\u00e9n n\u00e9ha le\u00e1ll\u00edthat\u00f3k, ha az \u00e9letm\u00f3dbeli v\u00e1ltoztat\u00e1sok tart\u00f3s 40\u201350%-os LDL-cs\u00f6kken\u00e9st \u00e9s jelent\u0151s 10 \u00e9ves kock\u00e1zatcs\u00f6kken\u00e9st eredm\u00e9nyeznek, de a kock\u00e1zat kontroll\u00e1l\u00e1sa ut\u00e1ni abbahagy\u00e1s \u00e1ltal\u00e1ban heteken bel\u00fcl visszavezeti az LDL-szintet a kezel\u00e9s el\u0151tti szintre.<\/p>\n<h3 class=\"wp-block-heading\">Mi a helyzet a sztatinok \u00e9s az izomf\u00e1jdalommal?<\/h3>\n<p>A sztatinszed\u0151k kb. 5\u201310%-a jelent izomf\u00e1jdalmat, de a SAMSON (2020) \u00e9s a StatinWISE (2021) \u2014 eleg\u00e1ns N-of-1 vizsg\u00e1latok vakolt sztatin\/placebo keresztez\u00e9ssel \u2014 azt mutatta, hogy a sztatinoknak tulajdon\u00edtott izomt\u00fcnetek kb. 90%-a val\u00f3j\u00e1ban placeb\u00f3t\u00f3l f\u00fcggetlen (ugyan\u00fagy el\u0151fordulnak placeb\u00f3n). Val\u00f3di sztatin-\u00f6sszef\u00fcgg\u00e9ses myalgia l\u00e9tezik; ha val\u00f3di, \u00e1ltal\u00e1ban megold\u00f3dik egy m\u00e1sik sztatinra v\u00e1lt\u00e1ssal, az adag cs\u00f6kkent\u00e9s\u00e9vel vagy alternat\u00edv napokon t\u00f6rt\u00e9n\u0151 szed\u00e9ssel. CK-m\u00e9r\u00e9st v\u00e9gezni s\u00falyos esetben; azonnali abbahagy\u00e1s \u00e9s orvosi seg\u00edts\u00e9gkeres\u00e9s sz\u00fcks\u00e9ges, ha s\u00falyos izomf\u00e1jdalom \u00e9s s\u00f6t\u00e9t vizelet (rhabdomyolysis) l\u00e9p fel.<\/p>\n<h3 class=\"wp-block-heading\">Should I take CoQ10 with Simvotin?<\/h3>\n<p>A sztatinok cs\u00f6kkentik a kering\u0151 CoQ10 szintet, de a CoQ10 p\u00f3tl\u00e1s (200 mg\/nap) randomiz\u00e1lt vizsg\u00e1latai nem mutattak k\u00f6vetkezetesen el\u0151nyt a sztatin-\u00f6sszef\u00fcgg\u00e9ses izomt\u00fcnetek eset\u00e9n. Biztons\u00e1gos, de az olcs\u00f3 p\u00f3tl\u00e1s nem helyettes\u00edti a tart\u00f3s izomf\u00e1jdalom megfelel\u0151 vizsg\u00e1lat\u00e1t.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol on Simvotin?<\/h3>\n<p>M\u00e9rs\u00e9kelt alkoholfogyaszt\u00e1s (1\u20132 egys\u00e9g\/nap) elfogadhat\u00f3. A s\u00falyos iv\u00e1s n\u00f6veli a m\u00e1jenzyme-emelked\u00e9s kock\u00e1zat\u00e1t, \u00e9s ker\u00fclni kell. Besz\u00e9ljen \u0151szint\u00e9n az orvos\u00e1val; az alkohol nagyobb m\u00e9rt\u00e9kben vezet m\u00e1jprobl\u00e9m\u00e1khoz, mint a sztatin.<\/p>\n<h3 class=\"wp-block-heading\">What if I forget to take Simvotin?<\/h3>\n<p>Vegye be, amint esz\u00e9be jut. Ha k\u00f6zel van a k\u00f6vetkez\u0151 tervezett adagol\u00e1shoz, hagyja ki \u00e9s folytassa a szok\u00e1sos m\u00f3don \u2013 ne dupl\u00e1zza meg az adagot.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Simvotin online?<\/h3>\n<p>You can order Simvotin (10 mg or 20 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 koleszterin-szint cs\u00f6kkent\u0151 gy\u00f3gyszerek<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/crestor\/\">Crestor \u2014 Rosuvastatin 5\/10\/20 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/lipvas\/\">Lipvas \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/atorvatin\/\">Atorvatin \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/rosuline\/\">Rosuline \u2014 Rosuvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/pivasta\/\">Pivasta \u2014 Pitavastatin 4 mg (interakci\u00f3mentes sztatin)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/ezedoc\/\">Ezedoc \u2014 Ezetimibe (kieg\u00e9sz\u00edt\u0151 a sztatinhoz)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/lipicard\/\">Lipicard \u2014 Fenofibr\u00e1t (triglicerid-szint cs\u00f6kkent\u0151)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/high-cholesterol-treatments\/\"><strong>\u00d6sszes magas koleszterin-szint\u0171 gy\u00f3gyszer b\u00f6ng\u00e9sz\u00e9se<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Orvosi nyilatkozat.<\/strong> Ez az oldal t\u00e1j\u00e9koztat\u00f3 jelleg\u0171, \u00e9s nem helyettes\u00edti az orvosi tan\u00e1csot egy k\u00e9pzett eg\u00e9szs\u00e9g\u00fcgyi szakembert\u0151l. S\u00falyos izomf\u00e1jdalom s\u00f6t\u00e9t vizelettel, megmagyar\u00e1zhatatlan s\u00e1rgul\u00e1s a b\u0151r\u00f6n\/szemeken, vagy hirtelen gyenges\u00e9g eset\u00e9n s\u00fcrg\u0151sen keressen orvosi seg\u00edts\u00e9get. A sztatinok X kateg\u00f3ri\u00e1ba tartoznak terhess\u00e9g alatt.<\/div>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Simvotin is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our <a href=\"\/hu\/medsbase-re-shipment-assurance-policy\/\">\u00dajrak\u00fcld\u00e9si Garancia<\/a>. A k\u00e1rty\u00e1s fizet\u00e9s sor\u00e1n a sz\u00e1mlakivonaton szerepl\u0151 le\u00edr\u00f3 a szab\u00e1lyozott fizet\u00e9si feldolgoz\u00f3t mutatja (egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t), soha nem a \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer nevet.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/cosart-h\/\">Cosart H<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/hydrocl\/\">Hydrocl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/calaptin-sr\/\">Calaptin SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/nise-gel\/\">Nise Gel<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/montek-plus\/\">Montek Plus<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Cholesterol lowering<br \/>\n\u2705 Heart health support<br \/>\n\u2705 Reduced risk of cardiovascular events<br \/>\n\u2705 Lowered LDL levels<br \/>\n\u2705 Improved lipid profile<\/p>\n<p>Simvotin contains Simvastatin.<\/p>","protected":false},"featured_media":59323,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4675,4676],"class_list":{"0":"post-59322","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-simvastatin","10":"product_tag-simvotin","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/59322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=59322"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/59323"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=59322"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=59322"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=59322"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=59322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}